Cresset Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,368
Closed -$521K 2011
2023
Q2
$521K Buy
+12,368
New +$500K ﹤0.01% 1260
2022
Q3
Sell
-3,488
Closed -$247K 975
2022
Q2
$247K Buy
3,488
+836
+32% +$61.1K ﹤0.01% 766
2022
Q1
$214K Buy
2,652
+285
+12% +$24.1K ﹤0.01% 890
2021
Q4
$243K Sell
2,367
-3,232
-58% -$310K ﹤0.01% 970
2021
Q3
$490K Buy
5,599
+160
+3% +$14.5K 0.01% 632
2021
Q2
$487K Buy
5,439
+599
+12% +$50.6K 0.01% 564
2021
Q1
$367K Buy
4,840
+1,291
+36% +$97.3K 0.01% 584
2020
Q4
$242K Buy
+3,549
New +$221K ﹤0.01% 635
2019
Q2
Sell
-210
Closed -$11K 1851
2019
Q1
$11K Buy
210
+179
+577% +$8.68K ﹤0.01% 1162
2018
Q4
$1K Buy
+31
New +$1.44K ﹤0.01% 1642

Other funds holding SYNH

Cresset Asset Management's SYNH Position: Q3 2023 in Review

Cresset Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 12,368 shares — an estimated $521K sold.

Cresset Asset Management first reported a position in SYNH in Q4 2018 and held it in 10 quarters. The position peaked at $521K in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Cresset Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Cresset Asset Management sold 12,368 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $521K.
  • Cresset Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2018 and held it in 10 quarters.
  • Cresset Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $521K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Cresset Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.